fingolimod hydrochloride has been researched along with Brain Thrombosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brunkhorst, R; Derouiche, A; Ferreirós, N; Foerch, C; Kanaan, N; Koch, A; Mirceska, A; Mittelbronn, M; Pfeilschifter, J; Pfeilschifter, W; Steinmetz, H; Zeiner, P | 1 |
1 other study(ies) available for fingolimod hydrochloride and Brain Thrombosis
Article | Year |
---|---|
FTY720 treatment in the convalescence period improves functional recovery and reduces reactive astrogliosis in photothrombotic stroke.
Topics: Aldehyde-Lyases; Animals; Astrocytes; Cerebral Cortex; Convalescence; Fingolimod Hydrochloride; Gene Expression; Gliosis; Immunosuppressive Agents; Intracranial Thrombosis; Male; Mice; Mice, Inbred C57BL; Post-Synaptic Density; Propylene Glycols; Recovery of Function; Reverse Transcriptase Polymerase Chain Reaction; Sphingosine; Stroke; Time Factors; Treatment Outcome; Vascular Endothelial Growth Factor A | 2013 |